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Two-Year Results for Sirolimus-Eluting Stents
The short-term results with sirolimus-eluting stents (SES) have shown impressiveefficacy, especially in the reduction of target vessel revascularization (TVR).
Theoretic considerations and biologic models have raised concern that sirolimus may
be simply delaying, rather than preventing, restenosis. Two papers in this issue report
on two-year outcomes with SES. The first paper reports two-year outcomes in patients
enrolled in the Sirolimus-Eluting Stent in De Novo Native Coronary Lesions
(SIRIUS) study which randomized patients to either bare-metal stents or SES. In this
trial, the benefits of SESweremaintained,withTVRreducedbymore than50%at two
years. The second paper is from the Rapamycin-Eluting Stent Evaluated at Rotterdam
Cardiology Hospital (RESEARCH) registry. Clinicians there have been preferentially
using SES sinceApril 2002. In this report, they compare patients treatedwith SESwith
patients who received bare metal stents in the immediate preceding period (pre-SES
group).Despite the SESpatients havingmore complex anatomy, the cumulativemajor
adverse cardiac event (MACE)was significantly reduced andTVRwas almost 50% less
frequent. Neither group reported evidence of either increased rates of stent thrombosis
or late restenosis in the second year after implantation. In an accompanying editorial,
Sigwart cautions that four-year clinical data is necessary before the safety of SES can be
unreservedly proclaimed and that the future of interventional cardiology will see the
introduction of improved stent patterning and drug delivery techniques. See pages
1350, 1356, and 1361.
Page 1366
Atherosclerosis
Temporal Changes in Coronary Artery Remodeling
Coronary arteries are known to undergo expansive remodeling, an increase in theexternal elastic membrane (EEM) cross-sectional area (CSA), as the amount of
plaque increases in an apparent attempt to maintain luminal CSA. Previous studies
have defined a remodeling index (RI), which is the lesion EEM CSA, divided by the
EEMCSA from a reference, non-diseased segment. This index is thought to represent
temporal changes, but does not directlymeasure these changes inEEMlumen size. von
Birgelen and colleagues measured the lumen CSA, EEMCSA, and the RI in serial left
main intravascular ultrasound studies separated by 18 months. They report that 60%
of the subjects had evidence of expansive remodeling according to the follow-up RI.
This resulted in a larger lumen size despite an increase in plaque burden. The other
40%had a reduction in lumen size due to increased plaque burden and a smaller EEM
CSA.Using regression analysis, the follow-upRIwas dependent on the baselineRI, the
increase in lesion EEM area, and the decrease in reference EEM area, but was not
dependent on changes in lesion plaque area. This paper helps to document temporal
changes in luminal CSA based on the presence of or absence of expansive remodeling
and our understanding of the functional significance of the RI. See page 1363.
See figure.
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Heart Rhythm Disorders
Robotic Manipulation for Pulmonary Vein Isolation
Pulmonary vein (PV) isolation is a well validated technique to prevent the recur-rence of atrial fibrillation, but the technique is technically challenging and time-
consuming. It relies on operator manipulation of external sheaths to obtain and
maintain precise locations in the left atriumusing fluoroscopic guidance. Pappone and
colleagues report on their experience using a remotely operated, magnetically driven
ablation catheter. Theoretically, this technique allows the use of softer catheters and
more stable and more accurate positioning. In the first reported experience from 40
patients, they were able to achieve satisfactory voltage abatement in 38 patients. After
an initial learning curve, the robotic device led to shorter ablation times with more
mapping points. Magnetically guided catheter ablation appears safe and effective for
PV isolation, with a steep, but short learning curve. See page 1390. See figure.
Page 1430
Cardiac Imaging
Adenosine CMR for Patients with Chest Pain
The management of patients with chest pain, but non-diagnostic electrocardio-grams and negative troponin remains challenging. Cardiac magnetic resonance
(CMR) imaging can detect wall motion abnormalities as well as previous myocardial
infarctions of even small size.The addition of vasodilator perfusion imagingmaydetect
flow limiting stenoses. Ingkanisorn and colleagues performed comprehensive CMR
studies on subjects within 72 h of presentation to an emergency room with a non-
diagnostic initial evaluation and followed them for clinical events over 1 year. Adeno-
sine perfusion abnormalities had 100% sensitivity and 93% specificity for the compos-
ite end points of a clinical cardiac event or a stenosis50% on coronary angiography.
This study demonstrates the CMRwith vasodilator perfusion has high sensitivity and
specificity for detecting clinically significant coronary artery disease in an emergency
room setting; no patientswith a normal adenosineCMRhad adverse cardiac outcomes
over the next year. See page 1427. See figure.
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Cardiovascular Effects
of Sleep Apnea
Treating Sleep Apnea Improves Biventricular Performance
While obstructive sleep apnea (OSA) is clearly associated with cardiac risk factorsincluding hypertension, there is mixed data on the effectiveness of treatment
with continuous positive airway pressure (CPAP) to reduce these effects. Shivalkar and
colleagues performeddetailed echocardiograms concentrating on right and left ventric-
ular systolic and diastolic function in patients with OSA. The severity of OSA was
found to correlate with intraventricular septal (IVS) thickness, evidence of right
ventricular dilation, and lower tissue Doppler velocities. Six months after treatment
withCPAP significant improvementswere observed in the symptomsofOSA, reduced
IVS thickness, and increased left ventricular stroke volume. The authors postulate that
the chronically elevated sympathetic drive produced by OSA is similar to the negative
effects of this milieu in congestive heart failure and by reducing this sympathetic drive
CPAP treatment is analogous to beta-blocker therapy.See page 1433. See figure.
Page 1458
Congenital Heart Disease
Percutaneous Repair of Aortic Coarctation
Surgical therapy for aortic coarctation (CoA) is associatedwith significantmorbidityand occasionally the development of aortic aneurysms. Tzifa and colleagues report
on their experience using a recently developed Cheatham-Platinum (CP) stent which
has gold reinforced welds and a PTFE covering. These stents were implanted in 33
patients deemed high risk for surgical intervention. The procedure was technically
successful with only two asymptomatic aneurysms/dissections and twominor bleeding
complications. The systolic gradient across the CoA was significantly reduced from a
mean of 36 to 4 mm Hg. All stents were patent and in good position on computed
tomography or magnetic resonance imaging performed three to six months later and
nearly one-half of patients were able to reduce or stop their antihypertensive medica-
tion. This covered stents appears to be a viable and safe alternative to surgical repair of
aortic coarctations. See page 1457. See figure.
